Reckitt Benckiser Group


28/11/24 -"Following the Q3 update, we have trimmed our near-term estimates to account for the higher-than-expected FX headwinds and interest expenses going into the end of 2024."

Pages
48
Language
English
Published on
28/11/24
You may also be interested by these reports :
28/11/24
Following the Q3 update, we have trimmed our near-term estimates to account for the higher-than-expected FX headwinds and interest expenses going ...

26/11/24
Unilever’s presentation of its Growth Action Plan 2030 reinforced our positive view of the company. The guiding principle of ‘fewer, better, greater’ ...

23/11/24
Henkel’s Q3 sales report fell short of expectations by 2.0%. Although the Hair segment has moved past its most challenging period regarding portfolio ...

13/11/24
Given Unilever’s (Reduce; UK) recent share price performance, now may not be the best moment to re-enter the stock. The upcoming CMD, two weeks from ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO